ROQ — Roquefort Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsSpeculativeMicro Cap
- £5.88m
- £5.88m
- £0.00m
Annual cashflow statement for Roquefort Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | |
|---|---|
| Period Length: | 12 M |
| Source: | ARS |
| Standards: | IFRS |
| Status: | Final |
| Net Income/Starting Line | -0.996 |
| Non-Cash Items | 0.365 |
| Other Non-Cash Items | |
| Changes in Working Capital | -1.99 |
| Change in Accounts Receivable | |
| Change in Inventories | |
| Change in Accounts Payable | |
| Cash from Operating Activities | -2.62 |
| Other Investing Cash Flow Items | -1.11 |
| Acquisition of Business | |
| Cash from Investing Activities | -1.11 |
| Financing Cash Flow Items | -0.159 |
| Other Financing Cash Flow | |
| Net Issuance / Retirement of Stock | |
| Cash from Financing Activities | 4.63 |
| Foreign Exchange Effects | |
| Beginning Cash Balance | |
| Ending Cash Balance | |
| Net Change in Cash | 0.9 |